logo

ALKEM vs GRANULES: Stock Comparison

ALKEM LABORATORIES vs GRANULES INDIAUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

ALKEM LABORATORIES is the larger company by market capitalisation. ALKEM LABORATORIES shows a lower P/E, a higher ROE and a higher dividend yield, while GRANULES INDIA shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALKEM leads 8; GRANULES leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALKEMGRANULES

Valuation lens

What price are you paying?

Market CapContext only
₹59,508 Cr
₹22,358 Cr
P/E RatioALKEM has the lower reading
27.58x ✓
30.39x
P/B RatioGRANULES has the lower reading
4.31x
3.99x ✓
EPSALKEM has the higher reading
₹180.84 ✓
₹7.26
Book ValueContext only
₹1,155.87
₹205.21
Dividend YieldALKEM has the higher reading
0.4% ✓
0.22%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ALKEM is the larger company
₹59,508 Cr vs ₹22,358 Cr
P/E Ratio
ALKEM has a lower P/E
27.58x vs 30.39x
P/B Ratio
GRANULES has a lower P/B
3.99x vs 4.31x
EPS
ALKEM has higher earnings per share
₹180.84 vs ₹7.26
Dividend Yield
ALKEM has a higher dividend yield
0.4% vs 0.22%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 14.6%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs -22.7%
ROE
ALKEM has a higher ROE
16.39% vs 9.11%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALKEMGRANULES
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALKEMGRANULES
Live Price₹5,013.5₹817
Day Change-0.03%1.16%
Volume49,3355.12 L
52-Week High₹5,933.5₹923.65
52-Week Low₹4,891.5₹529.85
Distance from 52W High-15.51%-11.55%

Valuation

MetricALKEMGRANULES
Market Cap₹59,508 Cr₹22,358 Cr
P/E Ratio27.58x30.39x
P/B Ratio4.31x3.99x
EPS₹180.84₹7.26
Book Value₹1,155.87₹205.21
Dividend Yield0.4%0.22%

Growth

MetricALKEMGRANULES
Revenue Growth (TTM YoY)14.6%22.8%
EPS Growth (TTM YoY)-22.7%31.3%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricALKEMGRANULES
ROE16.39%9.11%
ROCE11.48%9.07%
Net Margin15.65%11.15%
Operating Margin20.61%17.19%
Debt to Equity0.11x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALKEMGRANULES
Promoter Holding49.7%▼ 1.5 pp37.08%▼ 0.59 pp
FII Holding10.42%▲ 0.26 pp20.25%▲ 2.75 pp
DII Holding22.63%▲ 1.23 pp15.33%▼ 0.78 pp
Public Holding17.25%27.04%▼ 1.34 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALKEM LABORATORIES and GRANULES INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.